NCT06980350 2025-07-29Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant ImmunotherapySun Yat-sen UniversityCompleted156 enrolled
NCT06031376 2023-09-11Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRCHunan Cancer HospitalCompleted106 enrolled
NCT06011330 2023-08-30Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal CancerHunan Cancer HospitalCompleted70 enrolled